Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 3): Rapid Evidence Collection, Integration and Recommendation Formation
|更新时间:2024-01-25
|
Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 3): Rapid Evidence Collection, Integration and Recommendation Formation
Journal of Traditional Chinese MedicineVol. 65, Issue 3, Pages: 281-286(2024)
HU Ziteng,YAN Lijiao,ZHANG Yujing,et al.Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 3): Rapid Evidence Collection, Integration and Recommendation Formation[J].Journal of Traditional Chinese Medicine,2024,65(03):281-286.
HU Ziteng,YAN Lijiao,ZHANG Yujing,et al.Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 3): Rapid Evidence Collection, Integration and Recommendation Formation[J].Journal of Traditional Chinese Medicine,2024,65(03):281-286.DOI: 10.13288/j.11-2166/r.2024.03.010.
Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 3): Rapid Evidence Collection, Integration and Recommendation Formation
The lack of direct evidence is an important problem faced in the formation of recommendations in rapid living guidelines of traditional Chinese medicine under public health emergencies, and the supplementation of indirect evidence can be a key method to solve this problem. For the collection of evidence, the type of evidence required, including direct and indirect evidence, should be clarified, and ‘direct first’ principle for selecting evidence can be set to standardize and accelerate the guideline development. When integrating evidence, recommendations can be formed directly if there is sufficient direct evidence, while regarding insufficient direct evidence, recommendations need to be supplemented and improved by integrating indirect evidence. In addition, when the body of evidence contains evidence from multiple sources, it is suggested to rate the evidence according to “higher rather than lower” principle. Finally, when forming recommendations, the level of evidence, safety and economic efficiency should be taken into consideration to determine the strength of the recommendation.
关键词
Keywords
references
BHAUMIK S . Use of evidence for clinical practice guideline development [J]. Trop Parasitol , 2017 , 7 ( 2 ): 65 - 71 .
National Institute for Health and Care Excellence . Deve-loping NICE guidelines: the manual [EB/OL]. ( 2014-10-31 )[ 2023-08-09 ]. http://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869 http://www.nice.org.uk/process/pmg20/resources/developing-nice-guidelines-the-manual-pdf-72286708700869 .
SALIAN VS , WRIGHT JA , VEDELL PT , et al . COVID-19 transmission, current treatment, and future therapeutic strategies [J]. Mol Pharm , 2021 , 18 ( 3 ): 754 - 771 .
MORGAN RL , FLOREZ I , FALAVIGNA M , et al . Development of rapid guidelines: 3. GIN-McMaster guideline development checklist extension for rapid recommendations [J]. Health Res Policy Syst , 2018 , 16 ( 1 ): 63 .
SHEA BJ , REEVES BC , WELLS G , et al . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both [J]. BMJ , 2017 : j4008 . doi: 10.1136/bmj.j4008 http://dx.doi.org/10.1136/bmj.j4008 .
HIGGINS JPT , ALTMAN DG , GØTZSCHE PC , et al . The Cochrane collaboration's tool for assessing risk of bias in randomised trials [J]. BMJ , 2011 , 343 : d5928 . doi: 10.1136/bmj.d5928 http://dx.doi.org/10.1136/bmj.d5928 .
STANG A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses [J]. Eur J Epidemiol , 2010 , 25 ( 9 ): 603 - 605 .
BROZEK JL , AKL EA , ALONSO-COELLO P , et al . Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions [J]. Allergy , 2009 , 64 ( 5 ): 669 - 677 .
NING L , YANFANG M , JINGYA W , et al . Traditional Chinese medicine guidelines for coronavirus disease 2019 [J]. J Tradit Chin Med , 2020 , 40 ( 6 ): 891 - 896 .
KONIARIS LG , DRUGAS G , KATZMAN PJ , et al . Management of gastrointestinal lymphoma [J]. J Am Coll Surg , 2003 , 197 ( 1 ): 127 .
RAGHU G , COLLARD HR , EGAN JJ , et al . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management [J]. Am J Respir Crit Care Med , 2011 , 183 ( 6 ): 788 - 824 .
BATES SM , GREER IA , MIDDELDORP S , et al . VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines [J]. Chest , 2012 , 141 ( 2 Suppl ): e691 S-e736S.
BHASIN S , CUNNINGHAM GR , HAYES FJ , et al . Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline [J]. J Clin Endocr Metab , 2010 , 95 ( 6 ): 2536 - 2559 .
Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine (RALIG-TCM) (Part 2): Development Process and Key Steps during Preparation Stage
The Difficulties and Methodological Suggestions for the Recommendation Formation of Clinical Practice Guidelines of Traditional Chinese Medicine
An AI-Driven Research Pathway for Upholding Fundamental Principles and Breaking New Ground of Traditional Chinese Medicine Under the Guidance of Complexity Science
Digitalization of Traditional Chinese Medicine Clinical Practice Guidelines:Current Status,Challenges,and Application Scenarios
Review and Prospects of Standardization of the Discipline of Traditional Chinese Medicine Spleen-Stomach Diseases
Related Author
LI Xiaoling
CHE Qianzi
WANG Jingya
LI An
SHI Nannan
WANG Yanping
LIANG Ning
GAO Yicheng
Related Institution
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine/Institute for Excellence in Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine
School of Intelligent Science and Technology,University of Science and Technology Beijing
Tsinghua University
Guang 'anmen Hospital,China Academy of Chinese Medical Sciences
Institute for the History of Chinese Medicine and Medical Literature,China Academy of Chinese Medical Sciences